APO RESEARCH · REPORT
Vinpocetine
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Product & engineering
Understand the product.
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
Selected research
Industry Growth & Trends
Global Vinpocetine Industry Growth and Trends Forecast to 2032
Market perspective
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Vinpocetine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Vinpocetine market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vinpocetine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vinpocetine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Vinpocetine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Vinpocetine Market by Company
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Vinpocetine Segment by Type
Tablet
Injection
Vinpocetine Segment by Application
Household
Hospital
Vinpocetine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinpocetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vinpocetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinpocetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Injection
Applications
- Household
- Hospital
Companies covered
- Gedeon Richter
- Runhong
- Sun Pharma
- WZT
- PUDE
- Welman
- ZhiTong
- Liaoning Zhiying
- COVEX
- Northeast Pharma
- Micro Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Vinpocetine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Vinpocetine Sales Estimates and Forecasts (2021-2032)
- 1.3 Vinpocetine Market by Type
- 1.3.1 Tablet
- 1.3.2 Injection
- 1.4 Global Vinpocetine Market Size by Type
- 1.4.1 Global Vinpocetine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Vinpocetine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Vinpocetine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Vinpocetine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Vinpocetine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Vinpocetine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Vinpocetine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Vinpocetine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Vinpocetine Industry Trends
- 2.2 Vinpocetine Industry Drivers
- 2.3 Vinpocetine Industry Opportunities and Challenges
- 2.4 Vinpocetine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Vinpocetine Revenue (2021-2026)
- 3.2 Global Top Players by Vinpocetine Sales (2021-2026)
- 3.3 Global Top Players by Vinpocetine Price (2021-2026)
- 3.4 Global Vinpocetine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vinpocetine Major Company Production Sites & Headquarters
- 3.6 Global Vinpocetine Company, Product Type & Application
- 3.7 Global Vinpocetine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vinpocetine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vinpocetine Players Market Share by Revenue in 2025
- 3.8.3 2025 Vinpocetine Tier 1, Tier 2, and Tier 3
4 Vinpocetine Regional Status and Outlook
- 4.1 Global Vinpocetine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Vinpocetine Historic Market Size by Region
- 4.2.1 Global Vinpocetine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Vinpocetine Sales in Value by Region (2021-2026)
- 4.2.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Vinpocetine Forecasted Market Size by Region
- 4.3.1 Global Vinpocetine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Vinpocetine Sales in Value by Region (2027-2032)
- 4.3.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vinpocetine by Application
- 5.1 Vinpocetine Market by Application
- 5.1.1 Household
- 5.1.2 Hospital
- 5.2 Global Vinpocetine Market Size by Application
- 5.2.1 Global Vinpocetine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Vinpocetine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Vinpocetine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Vinpocetine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Vinpocetine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Vinpocetine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Vinpocetine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Vinpocetine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Gedeon Richter
- 6.1.1 Gedeon Richter Company Information
- 6.1.2 Gedeon Richter Business Overview
- 6.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Gedeon Richter Vinpocetine Product Portfolio
- 6.1.5 Gedeon Richter Recent Developments
- 6.2 Runhong
- 6.2.1 Runhong Company Information
- 6.2.2 Runhong Business Overview
- 6.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Runhong Vinpocetine Product Portfolio
- 6.2.5 Runhong Recent Developments
- 6.3 Sun Pharma
- 6.3.1 Sun Pharma Company Information
- 6.3.2 Sun Pharma Business Overview
- 6.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sun Pharma Vinpocetine Product Portfolio
- 6.3.5 Sun Pharma Recent Developments
- 6.4 WZT
- 6.4.1 WZT Company Information
- 6.4.2 WZT Business Overview
- 6.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 WZT Vinpocetine Product Portfolio
- 6.4.5 WZT Recent Developments
- 6.5 PUDE
- 6.5.1 PUDE Company Information
- 6.5.2 PUDE Business Overview
- 6.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 PUDE Vinpocetine Product Portfolio
- 6.5.5 PUDE Recent Developments
- 6.6 Welman
- 6.6.1 Welman Company Information
- 6.6.2 Welman Business Overview
- 6.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Welman Vinpocetine Product Portfolio
- 6.6.5 Welman Recent Developments
- 6.7 ZhiTong
- 6.7.1 ZhiTong Company Information
- 6.7.2 ZhiTong Business Overview
- 6.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 ZhiTong Vinpocetine Product Portfolio
- 6.7.5 ZhiTong Recent Developments
- 6.8 Liaoning Zhiying
- 6.8.1 Liaoning Zhiying Company Information
- 6.8.2 Liaoning Zhiying Business Overview
- 6.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
- 6.8.5 Liaoning Zhiying Recent Developments
- 6.9 COVEX
- 6.9.1 COVEX Company Information
- 6.9.2 COVEX Business Overview
- 6.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 COVEX Vinpocetine Product Portfolio
- 6.9.5 COVEX Recent Developments
- 6.10 Northeast Pharma
- 6.10.1 Northeast Pharma Company Information
- 6.10.2 Northeast Pharma Business Overview
- 6.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Northeast Pharma Vinpocetine Product Portfolio
- 6.10.5 Northeast Pharma Recent Developments
- 6.11 Micro Labs
- 6.11.1 Micro Labs Company Information
- 6.11.2 Micro Labs Business Overview
- 6.11.3 Micro Labs Vinpocetine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Micro Labs Vinpocetine Product Portfolio
- 6.11.5 Micro Labs Recent Developments
7 North America by Country
- 7.1 North America Vinpocetine Sales by Country
- 7.1.1 North America Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Vinpocetine Sales by Country (2021-2026)
- 7.1.3 North America Vinpocetine Sales Forecast by Country (2027-2032)
- 7.2 North America Vinpocetine Market Size by Country
- 7.2.1 North America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Vinpocetine Market Size by Country (2021-2026)
- 7.2.3 North America Vinpocetine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Vinpocetine Sales by Country
- 8.1.1 Europe Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Vinpocetine Sales by Country (2021-2026)
- 8.1.3 Europe Vinpocetine Sales Forecast by Country (2027-2032)
- 8.2 Europe Vinpocetine Market Size by Country
- 8.2.1 Europe Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Vinpocetine Market Size by Country (2021-2026)
- 8.2.3 Europe Vinpocetine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Vinpocetine Sales by Country
- 9.1.1 Asia-Pacific Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Vinpocetine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Vinpocetine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Vinpocetine Market Size by Country
- 9.2.1 Asia-Pacific Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Vinpocetine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Vinpocetine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Vinpocetine Sales by Country
- 10.1.1 South America Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Vinpocetine Sales by Country (2021-2026)
- 10.1.3 South America Vinpocetine Sales Forecast by Country (2027-2032)
- 10.2 South America Vinpocetine Market Size by Country
- 10.2.1 South America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Vinpocetine Market Size by Country (2021-2026)
- 10.2.3 South America Vinpocetine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Vinpocetine Sales by Country
- 11.1.1 Middle East and Africa Vinpocetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Vinpocetine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Vinpocetine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Vinpocetine Market Size by Country
- 11.2.1 Middle East and Africa Vinpocetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Vinpocetine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Vinpocetine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Vinpocetine Value Chain Analysis
- 12.1.1 Vinpocetine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Vinpocetine Production Mode & Process
- 12.2 Vinpocetine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Vinpocetine Distributors
- 12.2.3 Vinpocetine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst